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induced cell death is detectable within a few hours andEisuke Nishida,* Patricia Mathias, Shengcai Lin,²
Richard J. Ulevitch, Glen R. Nemerow, and Jiahuai Han does not require protein synthesis (Itoh et al., 1991;
Schulze-Osthoff et al., 1994; Nakajima et al., 1995). It isDepartment of Immunology
The Scripps Research Institute believed that Fas ligation leads to activation of a prote-
ase cascade that ultimately results in the transductionLa Jolla, CA 92037
*Institute of Virus Research of a death signal (Frazer and Evan, 1996). At least two
distinct ICE/Ced-3 family protease activities are re-Kyoto University
Sakyo-ku, Kyoto 606±01 quired for completion of the apoptotic pathway (Chow
et al., 1995; Los et al., 1995; Nicholson et al., 1995;Japan
²Institute of Molecular and Cell Biology Tewari et al., 1995; Enari et al., 1996a; Hasegawa et al.,
1996; Schlegel et al., 1996). One preferentially cleavesThe National University of Singapore
Singapore 119260 a YVAD tetrapeptide substrate, while the other preferen-
tially cleaves a DEVD tetrapeptide substrate (Enari etRepublic of Singapore
al., 1996b). While the final targets for this proteolytic
cascade have yet to be fully elucidated, a number of
potential ICE/Ced-3 family protease targets have beenSummary
identified, including ICE-related proteases themselves
(Shi et al., 1996; Srinivasula et al., 1996), protein kinaseFas/APO-1(CD95) ligation activates programmed cell
Cd (Emoto et al., 1995), poly(ADP-ribose) polymerasedeath, a cellular process that plays an important role
(PARP; Lazebnik et al., 1994; Tewari et al., 1995), andin the maturation of the host immune response. We
lamin (Takahashi et al., 1996). However, the mechanismshow that activation of a specific MAP kinase kinase
by which the apoptotic program is executed is still(MKK), MKK6b, is necessary and sufficient for Fas-
poorly understood.induced apoptosis of Jurkat T cells. MKK6b activation
Recently, attention has been directed to the role ofoccurs downstream of an interleukin-1 converting en-
mitogen activated protein (MAP) kinase cascades inpro-zyme-like (ICE-like) protease(s), while execution of the
grammed cell death. Both c-Jun N-terminal kinase (JNKapoptotic pathway by MKK6b requires both ICE- and
or stress activated protein kinase [SAPK]) and p38 MAPCPP32-like proteases. Surprisingly, the p38 MAP ki-
kinase activation have been suggested to be involvednase protein, a known substrate of MKK6b, does not
in apoptosis because of the correlation with apoptosisparticipate in Fas/MKK6b-mediated apoptosis. These
in PC12 pheochromatocytoma cells (Xia et al., 1995).findings indicate a divergence of the MKK6b signaling
Persistent JNK activation has also been observed inpathways, one of which activates p38 and leads to
radiation-induced apoptosis (Chen et al., 1996). Expres-regulation of gene expression, and one of which acti-
sion of a dominant negative SEK1 (MKK4 or JNKK1),vates the ICE/Ced-3 family of proteases and leads to
the upstream kinase of JNK, or a dominant negativecell death. These studies represent a demonstration
c-Jun mutant protein has also been reported to blockof an apoptotic pathway that is comprised of both
ceramide-mediated apoptosis in myeloid and endothe-the ICE/Ced-3 family of proteases and MAP kinase
lial cell lines (Verheij et al., 1996). However, knockout ofkinase 6.
the SEK1 gene does not prevent apoptosis of thymo-
cytes; instead, the cells become more susceptible toIntroduction
apoptosis in response to Fas ligation (Nishina et al.,
1997). Dominant negative JNK can effectively blockApoptosis, or programmed cell death, is a biological
c-Jun-dependent reporter gene expression, but has noprocess in multicellular organisms characterized by the
effect on MEKK1-mediated apoptosis (Johnson et al.,condensation of the nucleus and a distinctive pattern
1996). Activation of JNK by TNF also has been shownof chromosomal DNA fragmentation. Apoptosis occurs
to be independent of TNF-induced apoptosis (Liu et al.,in many different cell types and can be triggered by a
1996).variety of extracellular stimuli (Cleveland and Ihle, 1995;
The previous studies cited above illustrate the needAbbas, 1996; Henkart, 1996; Frazer and Evan, 1996; Hale
to better understand the precise role of MAP kinaseet al., 1996). Fas/APO-1(CD95) is a member of the tumor
cascades, as well as the specific components of thesenecrosis factor (TNF) receptor family of cell surface pro-
pathways, in programmed cell death. MAP kinase kinaseteins, and Fas ligand (FasL) is a member of the TNF
6 was identified by us and others in an effort to charac-family of proteins (Oehm et al., 1992; Suda et al., 1993;
terize the upstream activators of p38 (Han et al., 1996a;Smith et al., 1994; Nagata and Golstein, 1995). Fas medi-
Moriguchi et al., 1996; Raingeaud et al., 1996; Stein etates apoptotic celldeath whentriggered by FasL binding
al., 1996; Cuenda et al., 1997). It has been determinedor by antibody cross-linking (Itoh etal., 1991; Nagata and
that MKK6 can specifically activate the p38 MAP kinaseGolstein, 1995). It is well established that Fas-induced
but not JNK and extracellular-regulated protein kinaseapoptosis plays an important role in the development
(ERK; Han et al., 1996a; Raingeaud et al., 1996; Stein etand function of the immune system, including the pres-
ervation of peripheral T cell homeostasis and themainte- al., 1996). To date, three members of p38 group of MAP
kinases have been identified (Han et al., 1994; Jiang etnance of sites of immune privilege (Dhein et al., 1995;
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al., 1996; Lechner et al., 1996; Li et al., 1996). p38 and replication-defective adenovirus vectors to achieve nearly
100% delivery of dominant negative or constitutivelyp38b are widely expressed in all human tissues, while
p38g is enriched in muscle (Jiang et al., 1996; Lechner active forms of components of the p38 pathway into
Jurkat T cells, in order to assess the role of these mole-et al., 1996; Li et al., 1996). The stimuli for p38, p38b, and
p38g activation include the proinflammatory cytokines cules in Fas-induced apoptosis. Our studies demon-
strate that MKK6b is necessary for Fas-induced Jurkatsuch as TNF as well as physical-chemical stimuli such
as UV irradiation (Jiang et al., 1996; Cuenda et al., 1997). T cell death and that activation of MKK6b is sufficient
tocause cell apoptosis. Importantly, we find that MKK6bAll three members of the p38 group of MAP kinases can
be inhibited by a class of pyridinyl imidazoles such as or the MKK6b cascade is integrated between ICE/Ced-3
family proteases, suggesting that the T cell apoptosisSB202190, here termed 4-(4-fluorophenyl)-2-2(4-hydro-
xyphenyl)-5-(4-pyridyl)-imidazole (FHPI; Lee et al., 1994; signaling pathway is composed of the ICE/Ced-3 family
of proteases and a MAP kinase kinase, MKK6b.Jiang et al., 1996; Li et al., 1996). MKK3, a closely related
isoform of MKK6, has also been shown to be a specific
activator of p38 (Derijard et al., 1995; Han et al., 1996b; Results
Jiang et al., 1996; Raingeaud et al., 1996). Both MKK3
and MKK6 have a short form and a long form (the latter MKK6b Activation by Fas Ligation Induces
Jurkat T Cell Apoptosisare designated MKK3b and MKK6b; Han et al., 1996a,
1996b; Moriguchi et al., 1996), which are most likely To determine whether the p38 MAP kinase pathway
is involved in Fas-induced apoptosis, we first askedgenerated by differential splicing.
In the studies reported here, we have determined the whether the upstream kinases of p38, MKK3, and MKK6
are activated following Fas cross-linking. Since only therelationship between activation of molecules in the p38
MAP kinase cascade and those involved in apoptosis larger spliced forms of these two kinases, MKK3b and
MKK6b, are present in Jurkat cells (as determined byinduced by Fas cross-linking in Jurkat T cells. We used
Figure 1. MKK6b Is Activated by Fas Liga-
tion, and MKK6b Activity Induces Apoptosis
of Jurkat Cells
(A) Jurkat cells were treated with the CH-11
Fas MAb for varying times or with 0.4 M sorbi-
tol for 30 min, and then the cells were lysed.
The amount of MKK6b or MKK3b in the cell
lysate was determined and normalized by
Western blotting using anti-MKK6 or MKK3
polyclonal antibody (Moriguchi et al., 1996).
MKK6b or MKK3b were immunoprecipitated
with the anti-MKK6 or MKK3 antibody. The
MKK6b or MKK3b kinase activity in the immu-
noprecipitates was measured using GST-
p38(M) as a substrate. Reaction products
were electrophoresed on a 10% SDS-gel, and
substrate phosphorylation was detected by
autoradiography and quantitated by phos-
phorimager analysis. The data are represen-
tative of two experiments.
(B) Jurkat cells were incubated with 100 ng/
ml of the CH-11 Fas MAb for varying times,
and the number of viable cells and MKK6b
activity were then determined as described
above and in the Experimental Procedures.
Comparable results were obtained in two ex-
periments.
(C and D) Jurkat cells were infected for vary-
ing times with a control adenovirus or with
viruses encoding MKK6b or MKK3b. The
number of viable cells and the activity of
MKK6b or MKK3b in the cell lyates were de-
termined. The arrow indicates the approxi-
mate time at which adenovirus-transduced
gene products began to be expressed in in-
fected cells. The viability data represent the
average of three separate experiments.
(E) Jurkat cells were incubated for 20 hr with
or without recombinant adenoviruses or for
8 hr with the CH-11 Fas MAb prior to the
analysis of chromosomal DNA fragmentation,
as described in the Experimental Procedures.
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Figure 2. MKK6b Activation Is Required for
Apoptosis
(A) Jurkat cells were cultured for 24 hr with a
control adenovirus or with adenoviruses en-
coding HA-tagged MKK6b(A) or MKK3b(A),
followed by Fas ligation with CH-11 Fas MAb
for varying times. The number of viable cells
was determined. The data represent the aver-
age of two experiments. The expression lev-
els of virus-introduced proteins were deter-
mined by anti-HA MAb 12CA5 24 hr after
infection, as shown in the right panel.
(B) The effect of MKK(A) expression on Jurkat
cell DNA fragmentation was examined 8 hr
after Fas ligation.
Nothern blotting and RT-PCR; data not shown), this the stage of the cell cycle (Akli et al., 1993). Moreover,
ruled out the participation of shorter variants of these adenovirus vectors can transduce nearly 100% of Jurkat
two MKKs in Jurkat cell function. To determine the effect cells, and infection has no effect on cell viability (data
of Fas cross-linking on MKK6b or MKK3b activation, not shown). Recombinant adenoviruses encoding E mu-
Jurkat cells were treated with Fas MAb for different tants MKK6b, MKK3b, and MEK1 were transiently ex-
periods of time, and the kinase activity of these mole- pressed in Jurkat T cells. Each of the E mutants has
cules was measured. In these studies, we used cell been demonstrated, previously, to act as dominant ac-
lysates that contained equal amounts of MKK6b or tive (Han et al., 1996b; Jiang et al., 1996; Raingeaud et
MKK3b, as determined by Western blotting (Figure 1A). al., 1996; Stein et al., 1996; Verheij et al., 1996). Expres-
MKK6b and MKK3b were immunoprecipitated from cell sion of MKK6b(E) led to a dramatic increase (z70%) in
lysates by specific antibodies and subsequently exam- cell death (Figure 1C) 24 hr postinfection. A modest level
ined for their ability to phosphorylate a kinase-inactive of cell death (25%) was observed when MKK3b(E) was
p38 mutant (p38[M], K57 toM; Figures1A and 1B). MKK6b expressed (Figure 1D). In contrast, expression of domi-
activation was detected within 30 min after Fas cross- nant active MEK1 did not lead to any changes in cell
linking and reached a plateau (z6-fold) between 0.5 and viability (data not shown). The relative activity of MKK6b
1 hr. As shown in Figure 1A, no reduction of MKK6b or MKK3b in adenovirus-infected cells was determined
activity was found in the late time points (Figure 1A). In by an immunokinase assay using anti-MKK6 or anti-
contrast, MKK3b activation was not detected. However, MKK3 antibody. This assay showed that the activities of
as a positive control, MKK3b activation was demon- the transduced MKK6b(E) and MKK3b(E) proteins were
strated by increasing the osmolarity of the culture me- comparable (Figures 1C and 1D, top panels). The kinase
dium with sorbitol (Moriguchi et al., 1996). The kinetics activity of each protein was detected 12 hr after infec-
of MKK6b activation correlated well with the onset of tion, consistent with previously reported detection of
Fas-induced apoptosis, which occurred within 2 hr (Fig- adenovirus-encoded genes (Bett et al., 1994; Jomary et
ure 1B). Persistent activation of MKK6b may be due to al., 1994; Chang et al., 1995). Therefore, we concluded
the irreversible process of apoptosis.
that MKK6b(E)-mediated cell death occurred with simi-
MAP kinase kinase family members are activated by
lar kinetics as that induced by Fas ligation (Figures 1B
dual phosphorylation on two serine/threonine residues
and 1C). Importantly, MKK6b activity introduced intolocated between kinase domains VII and VIII. Substitu-
cells by an adenovirus vector issimilar to that of endoge-tion of these two phosphorylation sites with alanine (A)
nous kinase that is induced by Fas cross-linking (Figuresor glutamic acid (E) results in dominant negative and
1B and 1C). The similarity of the kinetics of apoptosisconstitutively active forms, respectively, of MEK1, the
induced by Fas ligation or by MKK6b(E) expression sug-kinase for the ERK group of MAP kinases (Cowley et
gested that Fas ligation and MKK6b(E) may executeal., 1994). We and others have used similar approaches
the cell death using a common signaling pathway. DNAto create dominant negative (A mutants) and constitu-
fragmentation patterns, characteristic of cells undergo-tively activated (E mutants) of MKK3b or MKK6b (Han
ing apoptosis, were also seen in cells expressing consti-et al., 1996b; Jiang et al., 1996; Moriguchi et al., 1996;
tutively activated MKK6b or Fas cross-linking (FigureRaingeaud et al., 1996; Stein et al., 1996). These mutants
1E). Interestingly, expression of constitutively activeallowed us to evaluate the role of these MKKs in Fas-
MKK3b, a closely related isoform of MKK6b, resulted inmediated cell death in Jurkat cells. To determine
only a modest level of cell death (25%; Figures 1B andwhether MKK6b plays a role in programmed cell death,
1C), even though both of these transiently expressedwe employed a recombinant adenovirus system. Impor-
proteins phosphorylate p38 (Han et al., 1996b; Jiang ettantly, adenovirus-mediated gene delivery does not de-
al., 1996; Moriguchi et al., 1996; Raingeaud et al., 1996)pend on cell proliferation; thus, the kinetics of transgene
expression in whole cell populations is independent of to a similar extent (Figures 1C and 1D, top panels).
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MKK6b Activation Is Necessary for Jurkat hr with the fluoromethyl ketone-derivitized tetrapeptide
YVAD; with VAD, which specifically inhibits ICE-like pro-Cell Apoptosis
To determine if MKK6b activation is required for Fas- teases; or with the DEVD inhibitory peptide, which spe-
cifically inhibits the CPP32-like proteases (Fearnheadinduced apoptosis, we tested whether expression of
dominant negative MKK6b (A mutant) effected Fas- et al., 1995 Enari et al., 1996b; Muzio et al., 1996; Pronk
et al., 1996). The cells were then treated with Fas MAbinduced cell death. MKK6b(A) was introduced into Jur-
kat cells by using adenovirus vectors, and 24 hr later the for an additional 2 hr to activate MKK6b, and then an
immunokinase assay was performed on cell lysatescells were treated with Fas MAb. Expression of MKK6b(A)
significantly increased the number of viable cells (Figure using p38(M) as a substrate. Treatment of cells with
YVAD or VAD caused dose-dependent inhibition of Fas-2A). The surviving cells were capable of proliferating 24
hr after Fas ligation, as determined by MTT assay (data induced MKK6b activation (Figure 4). Approximately
65% inhibition of MKK6b activation was achieved withnot shown). In contrast, expression of an equivalent
amount of MKK3b(A) had only a slight effect on Fas- 10 mM of YVAD or VAD, and nearly complete inhibition
was observed with 50 mM of these peptides. In contrast,induced apoptosis, and two other dominant negative
kinases, MEK1(A) and MKK4(A), had no effect (data not treatment of cells with DEVD had no effect on Fas-
induced MKK6b activation. These data suggest that anshown). MKK6b(A) but not MKK3b(A) also blocked Fas-
induced DNA fragmentation (Figure 2B). In parallel ex- ICE-like protease, but not CPP32-like proteases, pro-
motes MKK6b activation in the Fas signal pathway.periments, we observed that expression of MEK1(A),
MKK3b(A), MKK4(A), or MKK6b(A) alone did not affect
cell viability, as determined by trypan blue dye exclu- p38 MAP Kinase Activation Is Not
sion. Since MKK6b is activated by Fas cross-linking, Required for Apoptosis
and expression of MKK6b(A) is capable of interfering Since p38 is a known substrate of MKK6b, we next
with Fas-induced apoptosis, we conclude that MKK6b tested whether its activation is required for Fas-induced
is required for Fas-induced cell apoptosis. apoptosis. Treatment of Jurkat cells with Fas MAb
caused an 8-fold enhancement of p38 activation (Figure
5A). This occurred with similar kinetics to those pre-The N-Terminus of MKK6b Determines
the Specificity of the Apoptotic viously observed for MKK6b activation. Fas ligation did
not result in the activation of another MAP kinase, ERK2,Signaling Pathway
MKK3b and MKK6b have 80% identity at the amino acid thus demonstrating the specificity of this pathway.
To evaluate further the role of p38 in Fas-inducedsequence level (Figure 3A), and we did not detect a
difference in their ability to activate p38, as assessed apoptosis, we used adenovirus vectors to express two
dominant negative p38 mutants in Jurkat cells. One ofin in vitro kinase assay or in cotransfection assay in
cultured cells (Han et al., 1996b; Jiang et al., 1996; Mori- the p38 mutants, p38(M), has a substitution in the ATP-
binding site (K57 to M), while the other mutant (p38[AF])guchi et al., 1996; Raingeaud et al., 1996). However,
MKK6b, but not MKK3b, is required for Fas-induced contains an altered phosphorylation site (TGY180±182 to
AGF). Expression of these two mutants in a monocyteapoptosis (Figures 1 and 2), indicating that these mole-
cules have distinct apoptotic roles in Jurkat T cells. To cell line, THP-1, has been previously shown to have
dominant negative effects, as indicated by the inhibitiondetermine the structural basis for MKK6b in mediating
apoptosis, we generated chimeric proteins of MKK6b of LPS-induced TNF production (our unpublished data);
however, expression of either mutant did not affect Fas-and MKK3b. A comparison of the amino acid sequence
of these two proteins revealed that the N-terminus of or MKK6b-induced apoptosis, as determined by cell
viability (Figure 5B) or DNA fragmentation (Figure 5C).these proteins is dissimilar; therefore, chimeras were
created by swapping the N-terminal portion of these Furthermore, an imidazole derivative, FHPI (SB202190),
which has been previously shown to specifically blocktwo proteins, as diagramed in Figure 3B. Recombinant
adenovirus vectors encoding the chimeric proteins were activation of the p38 group of MAP kinases (Lee et al.,
1994; Jiang et al., 1996; Li et al., 1996), failed to blockthen used to infect Jurkat cells. As shown in Figures
3C and 3D, the 77 N-terminal amino acids of MKK6b either Fas- or MKK6b-induced apoptosis. Together,
these data indicate that p38 activation is not requiredconferred upon MKK3b the ability to promote apoptosis
in Jurkat cells. In contrast, the N-terminal portion of for Fas-induced apoptosis in Jurkat cells. This finding
isalso consistent with the observation that constitutivelyMKK3b rendered MKK6b incapable of inducing apop-
tosis. Since the activity of the expressed proteins are active MKK3b, which can activate p38 (Han et al., 1996b;
Jiang et al., 1996; Raingeaud et al., 1996), does not playcomparable in terms of phosphorylation of p38(M) (Fig-
ure 3C, top panel), we conclude that the 77 N-terminal a significant role in cell death (Figure 1D).
amino acids of MKK6b contain the functional domain
that directs the specificity for T cell apoptosis. ICE and CPP32-like Proteases Act Downstream
of MKK6b to Promote Cell Death
Further studies were performed to identify downstreamFas-Mediated MKK6b Activation Requires
ICE-like Protease(s) effectors of MKK6b that are involved in apoptosis, in-
cluding the ICE- and CPP32-like proteases. ProteasePrevious studies have indicated that Fas-induced cell
death requires activation of ICE/Ced-3 family proteases activities were assayed in cells induced to undergo
apoptosis by treatment with the Fas MAb or by expres-(Chow et al., 1995; Enari et al., 1996b). We therefore
asked whether these proteases were part of the MKK6b sion of MKK6b(E). Fas cross-linking induced a transient
increase in ICE-like protease(s) activity, which peakedapoptotic pathway. Jurkat cells were pretreated for 2
MKK6b and ICE/Ced-3 Proteases in Apoptosis
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Figure 3. The N-Terminus of MKK6b Determines Its Apoptotic Function
(A) An amino acid sequence comparison of MKK3b and MKK6b. The region of each molecule that was used to generate chimeric proteins is
depicted in italics.
(B) A schematic representation and location of the protein domains present in the MKK3b-MKK6b chimeras.
(C) The effect of MKK6b(E), MKK6±3(E), MKK3b(E), or MKK3±6(E) expression on Jurkat cell viability or (D) DNA fragmentation were determined
20 hr after recombinant virus infection. The MKK6b/MKK3b-like activity in the cell lysate was determined by immunokinase assay, as described
in Figure 1, using the mixture of anti-MKK3 and MKK6 antibody.
at 1 hr, as well as a sustained increase of CPP32-like activity may not be a direct cause of CPP32-like prote-
ase(s) activation. Expression of MKK6b(E) caused a sim-protease(s) activity (Figure 6A). ICE-like activity declined
below basal levels 4 hr after Fas ligation, while CPP32- ilar upregulation of CPP32-like protease(s) activity but
did not promote activation of the ICE-like protease (Fig-like activity continued to increase for up to 10 hr, sug-
gesting that the transient increase in ICE-like protease ure 6B). Expression of dominant negative MKK6b inhib-
ited Fas-induced CPP32-like protease(s) activity but not
ICE-like protease(s) activity (Figure 6C). As distinct from
Fas cross-linking, the induction of CPP32-like prote-
ase(s) activity by MKK6b(E) expression did not require
VAD-sensitive protease(s) (Figure 6D; Enari et al.,
1996b). Collectively, these data suggest that the ICE-
like protease(s) acts upstream of MKK6b, while CPP32-
like protease(s) activation acts downstream of MKK6b
activation. To identify the downstream protease(s) of
MKK6b, we examined the cleavage of a CPP32 group
protease, CPP32 (also term Yama; Tewari et al., 1995).
As shown in Figure 6E, MKK6b(E) expression led to
processing of pro-CPP32. CPP32 activation was dem-
onstrated by cleavage of its substrate, PARP, in the
same cells (Figure 6E, bottom panel). Thus, CPP32 is a
downstream protease of MKK6b.
Figure 4. Fas-Induced Activation of MKK6b Is Inhibited by the Syn- To test if protease activation was required for MKK6b-
thetic Peptide Protease Inhibitor YVAD or VAD but Not by DEVD
mediated apoptosis, we treated cells with synthetic
Jurkat cells were incubated for 2 hr with different amounts of prote-
peptide inhibitors of ICE- and CPP32-like proteases.ase inhibitors. The cells were then treated with the CH-11 Fas MAb
Peptide treatment had no effect on adenovirus-encodedfor an additional 2 hr, and MKK6b kinase activity was measured
gene expression (data not shown). MKK6b-mediatedusing immunokinase assay with GST-p38(M) as substrate. Compa-
rable results were obtained in three separate experiments. apoptosis was inhibited by treatment with the DEVD
Immunity
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Figure 5. p38 MAP Kinase Is Activated by Fas Ligation but Is Not Required for Apoptosis
(A) Jurkat cells were incubated with the CH-11 Fas MAb for varying times, and then p38 or ERK2 was recovered from cell lysates by
immunoprecipitation. The kinase activities of these molecules was measured using GST-ATF2(1±109) or MBP as substrates, respectively.
Comparable results were obtained in two experiments.
(B) Jurkat cells alone or cells infected with a control adenovirus, adenoviruses encoding p38(M) or p38(AF), or infection with a combination
of these viruses with or without a virus encoding MKK6b(E). Treatment of cells with 2 mM of the FHPI (SB202190) inhibitor was performed 2
hr before addition of the CH-11 Fas MAb or 6 hr after Ad-MKK6b(E) infection. The number of viable cells was determined or (C) the extent of
DNA fragmentation was examined 8 hr after Fas ligation or 20 hr after adenovirus infection.
peptide (Figure 7), indicating that CPP32 and/or CPP32- may influence substrate specificity or perhaps deter-
mine its subcellular location. However, immunohisto-like protease activity (Figure 6B) is required for apoptosis.
chemical and immunofluorescence studies have failedInterestingly, VAD also blocked MKK6b-induced cell
to demonstrate a difference in the subcellular location ofdeath (Figure 7), suggesting that ICE-like proteases
MKK6b and MKK3b (data not shown). Thus, the precisedownstream of MKK6b act to promote apoptosis. Since
mechanism by which the N-terminal sequence of MKK6bno change in ICE-like activity was detected in cells ex-
executes its specific function remains to be determined.pressing MKK6b(E) (Figure 6B), we conclude that either
We have examined in some detail the role of MKK3b inthe downstream ICE-like protease is present in very low
apoptosis. Consistent with previous reports using MKK3concentrations, or its activity is below the sensitivity of
(Xia et al., 1995; Juo et al., 1997), we observed someour protease assay. The fact that the protease inhibitor
enhancement of Fas-induced apoptosis by expres-VAD, which blocked MKK6b(E), induced cell death but
sion of the constitutively active form of MKK3b. In addi-failed to inhibit MKK6b(E)-induced CPP32-like activity
tion, we also observed that prolonged expression of(Figure 6D) excludes the possibility of a VAD-sensitive
MKK3b(E) (48 hrs) causes significant levels of cell deathprotease acting between MKK6b and CPP32-like pro-
(z70%). Since Fas-induced apoptosis is generallytease(s).
thought to be a relatively rapid cellular process (Itoh
et al., 1991; Schulze-Osthoff et al., 1994; Nagata and
Discussion
Golstein, 1995; Nakajima et al., 1995), the delayed cell
death induced by MKK3b(E) is unlikely to be related to
MKK6b Is Involved in Apoptosis of Jurkat T Cells Fas-induced apoptosis. This interpretation is consistent
While MKK6 and MKK3 have been shown to play an with the observation that MKK3b was not activated by
important role in the activation of p38 MAP kinases, Fas cross-linking in Jurkat cells (Figure 1A). Although
which subsequently results in many cellular responses, MKK3b is not involved in Fas-induced cell death, the
such as gene regulation (Lee et al., 1994; Han et al., participation of MKK3b in other cell death processes
1996a; Raingeaud et al., 1996; Han et al., 1997), the role induced by other triggering mechanisms cannot be ex-
of these two MKKs in apoptosis had not been eluci- cluded. TNF-induced cell death is another widely stud-
dated. The use of recombinant adenovirus vectors, ca- ied apoptosis process. TNF treatment of Jurkat cells
pable of efficient gene delivery and protein expression, also leads to apoptosis in the presence of cyclohexi-
has allowed us to demonstrate that the activation of mide. Expression of MKK6b(A) significantly inhibited
MKK6b, but not other MKKs, is necessary and sufficient TNF-induced apoptosis as well (data not shown), sug-
for T cell apoptosis induced by Fas ligation (Figures 1 gesting that this kinase is involved in T cell death trig-
and 2). The dramatically different abilities of two closely gered by multiple ligands.
related MKK isoforms, MKK3b and MKK6b, to promote Studies using thedominant negative kinases also indi-
apoptosis indicates that these isoforms are not redun- cated that MKK4 is not required for Fas-induced cell
dant, but rather participate in distinct cell processes. death. This finding is consistent with the recent report
The specificity of MKK6b in apoptosis is determined by that JNK activation is not linked to Fas- or TNF-induced
apoptosis (Liu et al., 1996; Lenczowski et al., 1997). Theits N-terminal portion sequence (Figure 3). This region
MKK6b and ICE/Ced-3 Proteases in Apoptosis
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Figure 7. Both Protease Inhibitors DEVD and VAD Block MKK6b(E)-
Mediated Apoptosis
Jurkat cell death was analyzed in cells cultured alone or in cells
that had been infected with a recombinant adenovirus encoding
MKK6b(E). The peptide inhibitors were added at the time of virus
infection. (A) cell viability and (B) DNA fragmentation were deter-
mined 20 hr after infection.
Evidence for Divergent Pathways
in MKK6b-Mediated Signaling
The potential involvement of p38 in apoptosis was sug-
gested by the observation that p38 activation correlates
Figure 6. ICE- and CPP32-like Protease(s) Activities in Jurkat Cells with apoptosis in the PC12 neuronal cell line, and by
Incubated with the Fas MAb or Expressing MKK6b(E) the fact that coexpression of MKK3(E) and p38 en-
(A) ICE- and CPP32-like protease activities were assayed in Jurkat hanced PC12 cell apoptosis (Xia et al., 1995). Our data
cells at varying times after Fas ligation. demonstrate that although p38 activation may occur
(B) ICE- and CPP32-like protease activity in Jurkat cells infected during cell death, this activation is not required forwith recombinant adenovirus encoding MKK6b(E). The arrow indi-
apoptosis (Figure 5). The fact that FHPI, a compoundcates the approximate time at which adenovirus transduced gene
known to inhibit the p38 group of MAP kinase activitiesproducts were detected.
(C) Interference of Fas ligation-induced protease activity by (Lee et al., 1994; Jiang et al., 1996; Li et al., 1996), did
MKK6b(A). The cells were infected with control virus or Ad- not have any inhibitory effect on Fas- or MKK6b(E)-
MKK6b(A) for 24 hr, and then the cells were treated with Fas MAb. induced apoptosis suggests that not only p38 but
ICE- and CPP32-like activity were assayed at varying times of Fas
also p38b and p38g are unlikely to be responsible forligation.
MKK6b(E)-induced cell death. These results suggests(D) Jurkat cells alone or cells infected with Ad-MKK6b(E) were ana-
the existence of an unknown substrate of MKK6b; theylyzed for protease activity 18 hr after infection. The peptide inhibitors
were added at the time of infection. also suggest that the p38 MAP kinase pathway diverges
(E) Expression of MKK6b(E) lead to cleavage of CPP32/Yama pro- after MKK6b. ICE-dependent p38 activation has been
enzyme and PARP detected by Western blotting using antibody recently reported (Juo et al., 1997), which supports the
against CPP32/Yama (PharMingen) or PARP (Biomol). Note that Fas notion that p38 is a downstream target of MKK6b in
ligation induces a transient increase in ICE-like protease activity,
Fas-ligated Jurkat cells. The concept that p38 activationwhile expression of MKK6b(E) does not. Both MKK6b(E) expression
is not associated with apoptosis is also supported byand Fas ligation induced a similar increase in CPP32-like activity.
MKK6b(A) inhibited Fas-induced CPP32-like activity, but not the previous studies, which show that inhibition of p38
ICE-like activity. Activation of CPP32-like protease(s) by MKK6b blocked TNF-induced IL-6 transcription but not apop-
does not occur through VAD-sensitive protease. tosis in murine L cells (Beyaert et al.,1996). Identification
of the unknown substrate(s) of MKK6b should provide
a better understanding of the mechanism(s) by which
small G protein Ras has also been implicated in Fas- this MAPK pathway impacts different cellularprocesses.
induced apoptosis in Jurkat cells (Gulbins et al., 1995).
Ras activation leads to ERK activation; however, we and ICE- and CPP32-like Proteases Act in Concert
others have shown that Fas cross-linking does not result with MKK6b to Promote Apoptosis
in ERK activation (Figure 5A; Wilson et al., 1996; Juo et The requirement of VAD-sensitive protease activity for
al., 1997). Moreover, expression of a dominant active or MKK6b activation by Fas cross-linking indicates that at
negative MEK1, the upstream kinase of ERK, had no least one ICE-family protease is an upstream element
influence on cell viability or apoptosis. These findings of MKK6b. One such candidate protease is FADD-like
suggest that although Ras may participate in Fas- ICE/Mort1-associated Ced-3 homolog (FLICE/MACH1;
induced apoptosis (Gulbins et al., 1995), activation of Boldin et al., 1996; Muzio et al., 1996). FLICE/MACH1
has been reported to interact directly with Fas in theMEK1 and ERK is not required for this process.
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The exact order of the putative VAD-sensitive protease
acting downstream of MKK6b, in relation to CPP32-like
protease(s), awaits further investigation.
In summary, it is believed that the Fas-mediated apop-
totic cascade is initiated by recruitment of the adaptor
molecule FADD and an ICE-family protease FLICE/
MACH1. The physical interaction of these molecules
activates FLICE/MACH1 by an unknown mechanism,
which then leads to the activation of a death signal
cascade. Our data indicate that MKK6b is an essential
component of this cascade. MKK6b acts downstream
of a YVAD-sensitive protease(s), and upstream of DEVD-
and YVAD-sensitive ICE/Ced-3 family proteases. The
MKK6b signaling pathway appears to have diverged
functionally, since one of its major substrates, p38, is
clearly not involved in apoptosis but instead plays a role
in transcriptional and posttranscriptional regulation of
gene expression (Han et al., 1993; Han et al., 1994; Lee
et al., 1994; Lee and Young, 1996; Beyaert et al., 1996;
Han et al., 1997). Since MKK6b activation requires its
phosphorylation, we speculate there is a kinase cas-
cade, rather than a single protein kinase inserted into
the T cell apoptotic pathway. A model of our proposed
Figure 8. A Proposed Model of the Fas-Activated Signaling Path- hierarchy of Fas-mediated apoptotic signaling mole-
ways in Jurkat T Cells
cules is shown in Figure 8. The finding that a MAP kinase
In the model, activation of MKK6b by the ICE-like protease(s) can
kinase is integrated into a protease cascade has shedlead to distinct cell functions. In one pathway, MKK6b activates
light on the complicated death signaling pathway. Thethe CPP32-like proteases and other ICE/Ced-3 family proteases to
mechanisms by which ICE-like protease(s) promotespromote cell death. In a separate pathway, MKK6b activates p38
and this ultimately leads to enhanced gene expression and/or other MKK6b activation, and how this process results in
cellular responses. CPP32 and CPP32-like protease(s) activation, are im-
portant questions that await future investigation.
death-inducing receptor complex and also to play an
Experimental Proceduresessential role in Fas-mediated apoptosis. Since the acti-
vation of MKK6b requires its phosphorylation on serine
Construction of Recombinant Adenovirus Vectorsand threonine residues, it is likely that a kinase acting
Encoding Apoptotic Signaling Molecules
directly upstream of this MAP kinase kinase is involved. The MKK and p38 mutant cDNAs were created as previously de-
A recently cloned MKK kinase, apoptosis signal-regulat- scribed (Cowley etal., 1994; Jiang et al., 1996). 3xHA-tagged MKK6b
and MKK3b were inserted into the pcDNA3 mammalian expressioning kinase 1 (ASK1; Ichijo et al., 1997), is a candidate
vector (Invitrogen, San Diego, CA) as described for MKK6 (Han etfor this kinase. ASK1 has been suggested to be involved
al., 1996a), using HindIII/XbaI sites. The MKK6b and MKK3b chimerain TNF-induced apoptosis and was shown to activate
cDNAs were generated by swapping the region encoding the 77MKK6 in a cotransfection assay (Ichijo et al., 1997).
N-terminal amino acid residues of MKK6b with the 88 N-terminal
Sequential activation of ICE- and CPP32-like prote- amino acid residues of MKK3b, using an internal BamHI site found
ases during Fas-mediated apoptosis has been pre- in both MKK6b and MKK3b.
Recombinant adenoviruses wereconstructed as follows. The ade-viously reported and is confirmed by our studies (Figure
novirus shuttle vector pAd/RSV was generated by subcloning the6A; Enari et al., 1996b). Our studies indicate that a pro-
RSV promoter-BGH polyA expression cassette from a pRC/RSVtein kinase cascade acts between the ICE- and CPP32-
vector (Invitrogen) into a pDE1sp1B (Microbix Biosystems, Toronto,like protease (Figure 6A), which involves MKK6b, since
Canada) vector, using the BamHI/BglII site. HA-tagged and non-
MKK6b activation is ICE-dependent, and its activation tagged MKK mutant cDNAs, MKK6b±MKK3b chimeras, and p38
can subsequently induce CPP32-like protease(s) activa- mutants were subcloned into the HindIII/XbaI site of pAd/RSV, while
MEK1 cDNA was inserted into this vector using EcoRV/XbaI. A por-tion in an ICE-independent fashion (Figures 4, 6B, 6C,
tion of each construct (15 mg) and an equivalent amount of theand 6D). The direct activator, CPP32-like protease(s),
adenovirus packaging plasmid pJM17 (Bett et al., 1994; Jomary etmust be an unidentified VAD-insensitive molecule. This
al., 1994; Chang et al., 1995) were cotransfected into the E1 trans-molecule could be a protease or a protein that can in-
complementing cell line 293, using calcium phosphate (Han et al.,
duce CPP32-like protease(s) self-processing. Further 1990). The recombinant adenoviruses, generated by homologous
studies are needed to investigate whether MKK6b has recombination, were isolated by plaque formation on 293 cells as
previously described (Bett et al., 1994; Jomary et al., 1994; Changa direct effect on protease activation. It is not surprising
et al., 1995). Viral DNA was isolated from at least five separatethat a VAD-sensitive protease(s) acts downstream of
plaques for each construct, and the insertion of MKKs or p38 cDNAsMKK6b-mediated apoptosis (Figure 7), because a VAD-
in the viral genome was confirmed by PCRusing Adv.for (59-TTTGACsensitive protease(s) downstream of CPP32 has been
CATTCACCACATTGG-39) and Adv.rev (59-AGATGGCTGGCAACTA
reported (Shi et al., 1996), and several ICE/Ced-3 family GAAG-39) primers and by restriction endonuclease digestion. The
proteases, such as Mch6 and Mch2, have been shown primer sequences of Adv.for and Adv.rev are derived from pRC/
RSV sites 574±594 and 731±750. High-titered stocks of recombinantto be possible targets of CPP32 (Srinivasula et al., 1996).
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adenoviruses were grown in 293 cells and purified by density gradi- were obtained by dividing the protease activity observed at each
time point by the values detected at time zero.ent ultracentrifugation (Chang et al., 1995). The titers of viral stocks
were approximately 1 3 1011 pfu/ml. A control recombinant adenovi-
rus lacking a cDNA insert was constructed by using pAd/RSV (an Analysis of Kinase Activities
empty vector) and pJM17. Immunoprecipitation and in vitro kinase assays were performed as
described previously (Raingeaud et al., 1995; Jiang et al., 1996).
Endogenous MKK3b, MKK6b, p38, and ERK2 were immunopre-Analysis of Gene Expression
cipitated using anti-MKK3, MKK6 (Moriguchi et al., 1996), p38Jurkat cells, 1 3 106 in a total volume of 2 ml, were incubated for
(Raingeaud et al., 1995), and ERK2 (UBI, Lake Placid, NY) polyclonalseveral time points with recombinant adenovirus at an multiplicity
antibodies. The substrate used for MKK6b and MKK3b is GST-of infection of 103 pfu/cell. The cells were then washed twice with
p38(M), the substrate used for p38 is GST-ATF2 (residues 1±109),phosphate buffered saline (PBS), and total RNA was subsequently
and the substrate used for ERK2 is MBP (Sigma).isolated from these cells (Trizol reagent, GIBCO-BRL). Total RNA (2
mg) was treated with 2 mg RQ1 RNase-free DNase (Promega) for 30
min, extracted with phenol:chloroform, and then used as a template Acknowledgments
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